ProPhase Labs, Inc. Operating Expenses
ProPhase Labs, Inc. (PRPH) reported Operating Expenses of $2.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-19
- ProPhase Labs, Inc. operating expenses for the quarter ending 2026-06-30 was $2.87M, a 37.96% decline year-over-year.
- ProPhase Labs, Inc. operating expenses for the quarter ending 2026-03-31 was $2.72M, a 35.04% decline year-over-year.
- ProPhase Labs, Inc. operating expenses for the quarter ending 2025-12-31 was $5.97M, a 65.15% decline year-over-year.
- ProPhase Labs, Inc. operating expenses for the quarter ending 2025-09-30 was $4.64M, a 30.68% decline year-over-year.
- ProPhase Labs, Inc. operating expenses for fiscal 2025 was $19.43M, a 49.50% decline from fiscal 2024.
- ProPhase Labs, Inc. operating expenses for fiscal 2024 was $38.48M, a 4.63% increase from fiscal 2023.
- ProPhase Labs, Inc. operating expenses for fiscal 2023 was $36.78M, a 21.85% decline from fiscal 2022.
- ProPhase Labs, Inc. operating expenses for fiscal 2022 was $47.06M, a 46.20% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.87M 10-Q · filed 2026-08-19 | $5.59M 10-Q · filed 2026-08-19 | $11.56M derived: sum of 3 quarters · filed 2026-08-19 | $16.21M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $2.72M 10-Q/A · filed 2026-07-09 | $2.77M 10-Q · filed 2026-06-30 | $8.69M derived: sum of 2 quarters · filed 2026-07-09 | $13.34M derived: sum of 3 quarters · filed 2026-07-09 | $17.96M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | $5.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $10.61M derived: sum of 2 quarters · filed 2026-06-01 | $15.24M derived: sum of 3 quarters · filed 2026-08-19 | $19.43M 10-K · filed 2026-06-01 | ||||
| 2025-09-30 | $4.64M 10-Q · filed 2025-11-19 | $9.27M derived: sum of 2 quarters · filed 2026-08-19 | $13.46M 10-Q · filed 2025-11-19 | $30.60M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $4.63M 10-Q · filed 2026-08-19 | $8.82M 10-Q · filed 2026-08-19 | $25.96M derived: sum of 3 quarters · filed 2026-08-19 | $32.65M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $4.19M 10-Q/A · filed 2026-07-09 | $21.33M derived: sum of 2 quarters · filed 2026-07-09 | $28.02M derived: sum of 3 quarters · filed 2026-07-09 | $35.10M derived: sum of 4 quarters · filed 2026-07-09 | ||||
| 2024-12-31 | $17.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $23.84M derived: sum of 2 quarters · filed 2026-06-01 | $30.91M derived: sum of 3 quarters · filed 2026-06-01 | $38.48M 10-K · filed 2026-06-01 | ||||
| 2024-09-30 | $6.70M 10-Q · filed 2025-11-19 | $7.77M 10-Q · filed 2024-11-13 | $13.77M derived: sum of 2 quarters · filed 2025-11-19 | $21.34M 10-Q · filed 2025-11-19 | $22.99M 10-Q · filed 2024-11-13 | $28.56M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $7.07M 10-Q · filed 2025-08-13 | $7.35M 10-Q · filed 2024-08-14 | $14.64M 10-Q · filed 2025-08-13 | $15.22M 10-Q · filed 2024-08-14 | $21.86M derived: sum of 3 quarters · filed 2025-08-13 | $30.67M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $7.57M 10-Q · filed 2025-05-20 | $7.87M 10-Q · filed 2024-05-10 | $14.79M derived: sum of 2 quarters · filed 2025-05-20 | $23.60M derived: sum of 3 quarters · filed 2025-05-20 | $34.70M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | $7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $16.02M derived: sum of 2 quarters · filed 2025-04-01 | $27.13M derived: sum of 3 quarters · filed 2025-04-01 | $36.78M 10-K · filed 2025-04-01 | $37.85M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $8.80M 10-Q · filed 2024-11-13 | $19.91M derived: sum of 2 quarters · filed 2024-11-13 | $29.56M 10-Q · filed 2024-11-13 | $45.93M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $11.11M 10-Q · filed 2024-08-14 | $20.75M 10-Q · filed 2024-08-14 | $37.12M derived: sum of 3 quarters · filed 2024-08-14 | $47.14M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $9.64M 10-Q · filed 2024-05-10 | $26.02M derived: sum of 2 quarters · filed 2024-05-10 | $36.04M derived: sum of 3 quarters · filed 2024-05-10 | $44.17M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $16.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $26.39M derived: sum of 2 quarters · filed 2024-03-29 | $34.53M derived: sum of 3 quarters · filed 2024-03-29 | $47.06M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $10.02M 10-Q · filed 2023-11-13 | $18.15M derived: sum of 2 quarters · filed 2023-11-13 | $30.69M 10-Q · filed 2023-11-13 | $41.63M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $8.13M 10-Q · filed 2023-08-11 | $20.66M 10-Q · filed 2023-08-11 | $31.61M derived: sum of 3 quarters · filed 2023-08-11 | $39.23M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $12.53M 10-Q · filed 2023-05-12 | $23.47M derived: sum of 2 quarters · filed 2023-05-12 | $31.10M derived: sum of 3 quarters · filed 2023-05-12 | $37.01M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $10.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $18.57M derived: sum of 2 quarters · filed 2023-03-29 | $24.48M derived: sum of 3 quarters · filed 2023-03-29 | $32.19M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $7.62M 10-Q · filed 2022-11-10 | $13.54M derived: sum of 2 quarters · filed 2022-11-10 | $21.25M 10-Q · filed 2022-11-10 | $25.77M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $5.92M 10-Q · filed 2022-08-12 | $13.62M 10-Q · filed 2022-08-12 | $18.14M derived: sum of 3 quarters · filed 2022-08-12 | $19.75M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $7.71M 10-Q · filed 2022-05-13 | $12.23M derived: sum of 2 quarters · filed 2022-05-13 | $13.84M derived: sum of 3 quarters · filed 2022-05-13 | $15.06M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $6.13M derived: sum of 2 quarters · filed 2022-03-31 | $7.35M derived: sum of 3 quarters · filed 2022-03-31 | $8.58M 10-K · filed 2022-03-31 | $8.59M 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $1.61M 10-Q · filed 2021-11-12 | $2.83M derived: sum of 2 quarters · filed 2021-11-12 | $4.06M 10-Q · filed 2021-11-12 | $5.52M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $1.22M 10-Q · filed 2021-08-13 | $2.45M 10-Q · filed 2021-08-13 | $3.91M derived: sum of 3 quarters · filed 2021-08-13 | $5.21M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.23M 10-Q · filed 2021-05-14 | $2.69M derived: sum of 2 quarters · filed 2021-05-14 | $3.99M derived: sum of 3 quarters · filed 2021-05-14 | $5.52M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $2.76M derived: sum of 2 quarters · filed 2021-03-31 | $4.29M derived: sum of 3 quarters · filed 2021-03-31 | $5.85M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $1.29M 10-Q · filed 2020-11-19 | $2.82M derived: sum of 2 quarters · filed 2020-11-19 | $4.39M 10-Q · filed 2020-11-19 | $6.13M derived: sum of 4 quarters · filed 2020-11-19 | ||||
| 2019-06-30 | $1.53M 10-Q · filed 2020-08-11 | $3.09M 10-Q · filed 2020-08-11 | $4.84M derived: sum of 3 quarters · filed 2020-08-11 | $6.51M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $1.56M 10-Q · filed 2020-05-12 | $3.31M derived: sum of 2 quarters · filed 2020-05-12 | $4.98M derived: sum of 3 quarters · filed 2020-05-12 | $6.50M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $3.42M derived: sum of 2 quarters · filed 2020-03-26 | $4.94M derived: sum of 3 quarters · filed 2020-03-26 | $6.42M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $1.67M 10-Q · filed 2019-11-12 | $3.19M derived: sum of 2 quarters · filed 2019-11-12 | $4.67M 10-Q · filed 2019-11-12 | $6.29M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $1.52M 10-Q · filed 2019-08-12 | $3.00M 10-Q · filed 2019-08-12 | $4.62M derived: sum of 3 quarters · filed 2019-08-12 | $5.96M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $1.48M 10-Q · filed 2019-05-14 | $3.10M derived: sum of 2 quarters · filed 2019-05-14 | $4.44M derived: sum of 3 quarters · filed 2019-05-14 | $6.19M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $2.96M derived: sum of 2 quarters · filed 2019-03-26 | $4.71M derived: sum of 3 quarters · filed 2019-03-26 | $5.94M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $1.33M 10-Q · filed 2018-11-14 | $3.08M derived: sum of 2 quarters · filed 2018-11-14 | $4.31M 10-Q · filed 2018-11-14 | $5.34M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $1.75M 10-Q/A · filed 2018-08-20 | $2.98M 10-Q/A · filed 2018-08-20 | $4.00M derived: sum of 3 quarters · filed 2018-08-20 | $4.93M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2017-03-31 | $1.23M 10-Q/A · filed 2018-08-20 | $2.25M derived: sum of 2 quarters · filed 2018-08-20 | $3.18M derived: sum of 3 quarters · filed 2018-08-20 | $4.48M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-12-31 | $1.02M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $1.95M derived: sum of 2 quarters · filed 2018-08-20 | $3.25M derived: sum of 3 quarters · filed 2018-08-20 | $4.79M 10-K/A · filed 2018-08-20 | $12.72M 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $930.00K 10-Q/A · filed 2018-08-20 | $1.94M 10-Q · filed 2016-11-14 | $2.23M derived: sum of 2 quarters · filed 2018-08-20 | $3.77M 10-Q/A · filed 2018-08-20 | $8.36M 10-Q · filed 2016-11-14 | -$3.05M derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-06-30 | $1.30M 10-Q/A · filed 2018-08-20 | $2.20M 10-Q · filed 2016-08-11 | $2.84M 10-Q/A · filed 2018-08-20 | $6.42M 10-Q · filed 2016-08-11 | -$3.98M derived: sum of 3 quarters · filed 2018-08-20 | -$1.86M derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-03-31 | $1.54M 10-Q/A · filed 2018-08-20 | $4.22M 10-Q · filed 2016-05-13 | -$5.28M derived: sum of 2 quarters · filed 2018-08-20 | -$3.17M derived: sum of 3 quarters · filed 2018-08-20 | -$592.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2015-12-31 | -$6.82M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$4.70M derived: sum of 2 quarters · filed 2018-08-20 | -$2.13M derived: sum of 3 quarters · filed 2018-08-20 | $2.91M 10-K/A · filed 2018-08-20 | $15.76M 10-K · filed 2016-03-29 | |||
| 2015-09-30 | $2.12M 10-Q · filed 2016-11-14 | $4.69M derived: sum of 2 quarters · filed 2016-11-14 | $9.73M 10-Q · filed 2016-11-14 | $16.30M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | $2.57M 10-Q · filed 2016-08-11 | $7.61M 10-Q · filed 2016-08-11 | $14.19M derived: sum of 3 quarters · filed 2017-02-24 | $20.91M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $5.04M 10-Q · filed 2016-05-13 | $11.61M derived: sum of 2 quarters · filed 2017-02-24 | $18.34M derived: sum of 3 quarters · filed 2017-02-24 | $22.27M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $6.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $13.30M derived: sum of 2 quarters · filed 2017-02-24 | $17.23M derived: sum of 3 quarters · filed 2017-02-24 | $22.01M 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $6.72M 10-Q · filed 2015-11-13 | $10.65M derived: sum of 2 quarters · filed 2015-11-13 | $15.44M 10-Q · filed 2015-11-13 | $21.42M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-06-30 | $3.93M 10-Q · filed 2015-08-12 | $8.71M 10-Q · filed 2015-08-12 | $14.70M derived: sum of 3 quarters · filed 2016-03-29 | $17.27M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-03-31 | $4.78M 10-Q · filed 2015-05-13 | $10.77M derived: sum of 2 quarters · filed 2016-03-29 | $13.35M derived: sum of 3 quarters · filed 2016-03-29 | $15.99M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2013-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $8.56M derived: sum of 2 quarters · filed 2016-03-29 | $11.21M derived: sum of 3 quarters · filed 2016-03-29 | $16.25M 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | $2.58M 10-Q · filed 2014-11-13 | $2.58M 10-Q · filed 2013-11-13 | $5.22M derived: sum of 2 quarters · filed 2014-11-13 | $10.27M 10-Q · filed 2014-11-13 | $10.28M 10-Q · filed 2013-11-13 | $15.51M derived: sum of 4 quarters · filed 2015-03-27 | ||
| 2013-06-30 | $2.65M 10-Q · filed 2014-08-12 | $2.65M 10-Q · filed 2013-08-13 | $7.69M 10-Q · filed 2014-08-12 | $7.70M 10-Q · filed 2013-08-13 | $12.93M derived: sum of 3 quarters · filed 2015-03-27 | $15.25M derived: sum of 4 quarters · filed 2015-03-27 | ||
| 2013-03-31 | $5.05M 10-Q · filed 2014-05-12 | $5.05M 10-Q · filed 2013-05-10 | $10.28M derived: sum of 2 quarters · filed 2015-03-27 | $12.61M derived: sum of 3 quarters · filed 2015-03-27 | $15.37M derived: sum of 4 quarters · filed 2015-03-27 | |||
| 2012-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $7.56M derived: sum of 2 quarters · filed 2015-03-27 | $10.32M derived: sum of 3 quarters · filed 2015-03-27 | $15.35M 10-K · filed 2015-03-27 | ||||
| 2012-09-30 | $2.33M 10-Q · filed 2013-11-13 | $5.08M derived: sum of 2 quarters · filed 2013-11-13 | $10.11M 10-Q · filed 2013-11-13 | $16.75M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-06-30 | $2.76M 10-Q · filed 2013-08-13 | $7.79M 10-Q · filed 2013-08-13 | $14.42M derived: sum of 3 quarters · filed 2014-03-27 | $16.91M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-03-31 | $5.03M 10-Q · filed 2013-05-10 | $11.66M derived: sum of 2 quarters · filed 2014-03-27 | $14.15M derived: sum of 3 quarters · filed 2014-03-27 | $16.03M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2011-12-31 | $6.63M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $9.12M derived: sum of 2 quarters · filed 2014-03-27 | $11.00M derived: sum of 3 quarters · filed 2014-03-27 | $14.02M 10-K · filed 2014-03-27 | ||||
| 2011-09-30 | $2.49M 10-Q · filed 2012-11-14 | $4.37M derived: sum of 2 quarters · filed 2012-11-14 | $7.39M 10-Q · filed 2012-11-14 | $12.15M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-06-30 | $1.88M 10-Q · filed 2012-08-13 | $4.90M 10-Q · filed 2012-08-13 | $9.66M derived: sum of 3 quarters · filed 2013-03-28 | $12.34M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-03-31 | $3.02M 10-Q · filed 2012-05-11 | $7.78M derived: sum of 2 quarters · filed 2013-03-28 | $10.46M derived: sum of 3 quarters · filed 2013-03-28 | $13.21M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2010-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $7.44M derived: sum of 2 quarters · filed 2013-03-28 | $10.19M derived: sum of 3 quarters · filed 2013-03-28 | $12.42M 10-K · filed 2013-03-28 | ||||
| 2010-09-30 | $2.67M 10-Q · filed 2011-11-14 | $5.42M derived: sum of 2 quarters · filed 2011-11-14 | $7.66M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $2.75M 10-Q · filed 2011-08-12 | $4.98M 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | $15.50M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |